The Patent Finder

Terms ending in 2035

Exosome Diagnostics, Inc.

Every in-force patent on Exosome Diagnostics, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,268,085Methods for Isolating Microvesicles and Extracting Nucleic Acids from Biological Samples
In force
 · High confidence
Exact Sciences CorporationIn forceHigh confidence
US 10,301,681Methods of Treating a Subject with a High Gleason Score Prostate Cancer
In force
 · High confidence
Exosome Diagnostics, Inc.In forceHigh confidence
US 10,465,183Methods for Isolating Microvesicles and Extracting Nucleic Acids from Biological Samples
In force
 · High confidence
Exact Sciences CorporationIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Exosome Diagnostics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited